Infectious Diseases. Ebola vaccine trials raise ethical issues.

Science (New York, N.Y.)

Volumn 346, Issue 6207, 2014, Pages 289-290

  Cohen, Jon ^a   Kupferschmidt, Kai ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EBOLA VACCINE;

DOUBLE BLIND PROCEDURE; EBOLA HEMORRHAGIC FEVER; ETHICS; GUINEA; HUMAN; LIBERIA; NOTE; PHASE 3 CLINICAL TRIAL (TOPIC); RANDOMIZED CONTROLLED TRIAL (TOPIC); SIERRA LEONE; WORLD HEALTH ORGANIZATION;

CLINICAL TRIALS, PHASE III AS TOPIC; DOUBLE-BLIND METHOD; EBOLA VACCINES; GUINEA; HEMORRHAGIC FEVER, EBOLA; HUMANS; LIBERIA; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SIERRA LEONE; WORLD HEALTH ORGANIZATION;

EID: 84908391388     PISSN: None     EISSN: 10959203     Source Type: Journal    
DOI: 10.1126/science.346.6207.289     Document Type: Note

References (0)